Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Koya Medical has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in November 2023.
Koya Medical's investors include National Science Foundation, Arboretum Ventures, OrbiMed, Bolt, Aphelion Capital.
Koya Medical is headquartered in Oakland, United States.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Koya Medical is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Koya Medical — Funding & Investors." VCBacked, November 15, 2023, https://www.vcbacked.co/company/koya-medical. Accessed August 1, 2026.
VCBacked. (2023). Koya Medical — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/koya-medical
{{cite web |title=Koya Medical — Funding & Investors |url=https://www.vcbacked.co/company/koya-medical |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated